Labeling Updates For Old Drugs Could Be Faster Under Streamlining Proposal

 
• By Sue Sutter

Stakeholder group's proposed pilot program to correct outdated drug labeling calls for US FDA to identify older products needing updates and contract out for evidence reviews, but agency and generic drug industry raise concerns about complexity, resources and product liability.

Arrow flying to target with radial motion blur
Can Friends of Cancer Research's proposal to update labeling hit the target and not harm anything else?

More from Approval Standards

More from Pathways & Standards